Calithera Biosciences, Inc. (NASDAQ:CALA – Get Free Report)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.01 and traded as low as $0.00. Calithera Biosciences shares last traded at $0.00, with a volume of 407 shares traded.
Wall Street Analysts Forecast Growth
Separately, StockNews.com initiated coverage on Calithera Biosciences in a research note on Saturday. They set a “hold” rating on the stock.
Check Out Our Latest Analysis on CALA
Calithera Biosciences Price Performance
About Calithera Biosciences
Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.
Further Reading
- Five stocks we like better than Calithera Biosciences
- Best Aerospace Stocks Investing
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- There Are Different Types of Stock To Invest In
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
